Picture of Vaxart logo

VXRT — Vaxart News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapTurnaround

Vaxart Inc reports results for the quarter ended in June - Earnings Summary

* Vaxart Inc  VXRT.OQ  reported a quarterly adjusted loss
of 16
cents​​ per share for the quarter ended in June. The mean
expectation of three analysts for the quarter was for a loss
of 18 cents per share.
    * Revenue was $1.36 million​; analysts expected $83.33
thousand. 
    * Vaxart Inc's reported EPS for the quarter was a loss of 16
cents​.
    * The mean earnings estimate of analysts had fallen by
about 5.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Vaxart Inc shares had risen by 3.8% this quarter and
lost 21.1%
so far this year.
    * The company reported a quarterly loss of $22.55 million.
    * Wall Street's median 12-month price target for Vaxart Inc
is
$6.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 3 at 09:49 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.18          -0.16          Beat
 Mar. 31 2023      -0.19          -0.19          Met
 Dec. 31 2022      -0.23          -0.18          Beat
 Sep. 30 2022      -0.24          -0.23          Beat

Recent news on Vaxart

See all news